Robeco Schweiz Ag Myriad Genetics Inc Transaction History

Robeco Schweiz Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 18, 2019	SELL	$22.08 - $47.08 $359,904 - $767,404	-16,300 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$22.67 - $35.0 $26,750 - $41,300	1,180 Added 7.8%	16,300 $436,000
Q1 2019 May 14, 2019	BUY	$26.93 - $34.7 $75,942 - $97,854	2,820 Added 22.93%	15,120 $502,000
Q4 2018 Feb 01, 2019	BUY	$27.23 - $45.56 $253,239 - $423,708	9,300 Added 310.0%	12,300 $352,000
Q3 2018 Oct 30, 2018	SELL	$37.57 - $50.34 $44,821 - $60,055	-1,193 Reduced 28.45%	3,000 $139,000
Q2 2018 Aug 09, 2018	BUY	$27.75 - $40.17 $33,105 - $47,922	1,193 Added 39.77%	4,193 $156,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,000	3,000 $77,000

237

92.7M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.8B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Robeco Schweiz Ag, based on Form 13F filings with the SEC.

Stay updated on Robeco Schweiz Ag with notifications on news.